MAPK1 and lymphoma: Although we cannot rule out that the other kinases we see being phosphorylated play an important role in the phenotype of Eμ-Myc/cRel−/− lymphomas, we decided to focus on potential changes to the AKT, JNK, ERK and p38 MAPK signalling pathways as these constitute highly studied and druggable targets.